Rocket Pharmaceuticals (RCKT) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Rocket Pharmaceuticals (RCKT) over the last 7 years, with Q3 2025 value amounting to -$0.45.
- Rocket Pharmaceuticals' EPS (Weighted Average and Diluted) rose 3661.97% to -$0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.25, marking a year-over-year increase of 1758.24%. This contributed to the annual value of -$2.73 for FY2024, which is 653.55% up from last year.
- Rocket Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to -$0.45 in Q3 2025, which was up 3661.97% from -$0.62 recorded in Q2 2025.
- In the past 5 years, Rocket Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of -$0.45 in Q3 2025 and a low of -$0.89 during Q4 2022
- For the 5-year period, Rocket Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$0.7, with its median value being -$0.68 (2021).
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first skyrocketed by 3761.47% in 2021, then plummeted by 5090.91% in 2022.
- Over the past 5 years, Rocket Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.68 in 2021, then plummeted by 30.88% to -$0.89 in 2022, then soared by 30.34% to -$0.62 in 2023, then dropped by 2.63% to -$0.64 in 2024, then grew by 29.28% to -$0.45 in 2025.
- Its last three reported values are -$0.45 in Q3 2025, -$0.62 for Q2 2025, and -$0.56 during Q1 2025.